NewDays delivers personalized cognitive treatment combining expert-led telehealth therapy with AI-powered daily practice for people with mild cognitive impairment (MCI) or early dementia. Our non-drug, science-backed program aims to maintain cognitive function, improve mental health, and help people stay independent longer. Founded in 2024 by leaders from Amazon and Google X, NewDays makes clinically validated cognitive interventions accessible at scale through breakthrough AI technology supervised by licensed clinicians.

We offer clinician-supervised AI brain training (Sunny) that provides guided exercises between telehealth sessions, personalized programs, and continuous progress monitoring. The program is available from home and—where applicable—covered by Medicare in participating states. Peer-reviewed clinical data show measurable improvements in cognitive function and mental health, and evidence of delayed symptom progression reported at AD/PD Conference (2026).